www.BuyersGuideChem.de enthält Produzenten und Lieferanten von Chemikalien, pharmazeutischen Wirkstoffen, APIs und anderen chemischen Substanzen
Hydranal Logo
Willkommen Über BGC Nutzungsbedingungen Werbebanner Impressum
BGC > Produktsuche > (3alpha,5beta,6E)-6-Ethylidene-3-hydroxy-7-oxocholan-24-oic acid | 1516887-33-4
english deutsch español

Lieferanten für CAS

1516887-33-4

Daten

CAS   1516887-33-4 
Formula   C26H40O4 

13 Registerierte Lieferanten

Junwee Chemical Co., Ltd. P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid  
Dayang Chem (Hangzhou) Co.,Ltd. P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid  
Hangzhou Keying Chem Co., Ltd. P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid  
H&Z Industry Co.,Ltd P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid  
Leap Chem Co., Ltd P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid   CD details
rd Obeticholic acid intermediate  
Beijing Pure Chem. Co., Ltd. P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid  
Guangzhou Topwork Chemical Co., Ltd. P.R.China
rd Obeticholic acid intermediate  
Nantong Xindao Biotech Ltd P.R.China
rd (3alpha,5beta,6E)-6-Ethylidene-3-hydroxy-7-oxocholan-24-oic acid  
Finetech Industry Limited P.R.China
rd (4R)-4-[(3R,5R,6E,8S,9S,10R,13R,14S,17R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxo-2,3,4,5,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid   CD details
Hangzhou Lingrui Chemical Co., Ltd. P.R.China
rd Obeticholic acid intermediate  
Shandong SanYoung Industry Co., Ltd P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid   CD details
Autech Industry Co.,Limited P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid  
Chemlyte Solutions P.R.China
rd (E)-3a-hydroxy-6-ethylidene-7-keto-5b-cholan-24-oic acid   CD details
Detaillierte Informationen über die Lieferanten von (3alpha,5beta,6E)-6-Ethylidene-3-hydroxy-7-oxocholan-24-oic acid
© Copyright 1996 bis 2024 Netvertise GmbH. Alle Rechte vorbehalten.